Dr. Andrew W. Walter

Pediatric Hematology Oncology
A.i. Dupont Hospital For Children, 1600 Rockland Road, 
Wilmington, DE 
A.i. Dupont Hospital For Children, 1600 Rockland Road, 
Wilmington, DE 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Andrew Walter is a Pediatric Hematologist Oncology provider in Wilmington, Delaware. Dr. Walter is rated as an Experienced provider by MediFind in the treatment of DICER1 Syndrome. His top areas of expertise are Medulloblastoma, Glioma, Acute Lymphoblastic Leukemia (ALL), and Embryonal Tumor with Multilayered Rosettes.

His clinical research consists of co-authoring 26 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in DE
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

A.i. Dupont Hospital For Children, 1600 Rockland Road, Wilmington, DE 19803

Additional Areas of Focus

Dr. Walter has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)
Neurofibromatosis Type 1 (NF1)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Managed Access Program (MAP) Cohort Treatment Plan CBYL719F12001M to Provide Access to Alpelisib (BYL719) for Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Enrollment Status: Available
Publish Date: December 02, 2025
Intervention Type: Drug
A Phase 2 Study of Veliparib (ABT-888) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients With Newly Diagnosed High-Grade Glioma (HGG) Without H3 K27M or BRAFV600 Mutations
A Phase 2 Study of Veliparib (ABT-888) and Local Irradiation, Followed by Maintenance Veliparib and Temozolomide, in Patients With Newly Diagnosed High-Grade Glioma (HGG) Without H3 K27M or BRAFV600 Mutations
Enrollment Status: Active_not_recruiting
Publish Date: November 13, 2025
Intervention Type: Drug, Radiation
Study Drugs: Temozolomide, Veliparib
Study Phase: Phase 2
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients With Newly Diagnosed Ependymoma Ages 1 to 21 Years
Enrollment Status: Active_not_recruiting
Publish Date: October 27, 2025
Intervention Type: Drug, Radiation, Biological, Other
Study Drugs: Carboplatin, Cisplatin, Cyclophosphamide, Etoposide, Vincristine
Study Phase: Phase 3
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
A Phase 2 Study of Reduced Therapy for Newly Diagnosed Average-Risk WNT-Driven Medulloblastoma Patients
Enrollment Status: Active_not_recruiting
Publish Date: August 12, 2025
Intervention Type: Drug, Procedure, Radiation, Other
Study Drugs: Cisplatin, Cyclophosphamide, Lomustine, Vincristine, Vincristine Sulfate
Study Phase: Phase 2
AflacST1502: A Phase II Study of Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
AflacST1502: A Phase II Study of Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2025
Intervention Type: Drug
Study Drugs: Sirolimus, Celecoxib, Etoposide, Cyclophosphamide
Study Phase: Phase 2
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
A Phase I Trial of Dose Escalation of Metformin in Combination With Vincristine, Irinotecan, and Temozolomide in Children With Relapsed or Refractory Solid Tumors
Enrollment Status: Completed
Publish Date: January 13, 2023
Intervention Type: Drug
Study Drugs: Vincristine, Irinotecan, Temozolomide, Metformin
Study Phase: Phase 1
View 5 Less Clinical Trials

26 Total Publications

Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response.
Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response.
Journal: Cell reports
Published: September 10, 2024
Similar Doctors
Experienced in DICER1 Syndrome
Dr. Renee C. Gresh
Pediatrics | Hematology | Oncology
Experienced in DICER1 Syndrome
Dr. Renee C. Gresh
Pediatrics | Hematology | Oncology
1600 Rockland Rd, 
Wilmington, DE 
 (1.6 miles away)
302-651-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Renee Gresh is a Pediatrics specialist and a Hematologist in Wilmington, Delaware. Dr. Gresh is rated as an Advanced provider by MediFind in the treatment of DICER1 Syndrome. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Sickle Cell Disease, Hepatoblastoma, Jaundice, and Liver Embolization. Dr. Gresh is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Walter's expertise for a condition
ConditionClose
    View All 22 Advanced Conditions
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile